REFERENCES
- Bellomo R, Teede H, Boyce N. Anticoagulant regimens in acute continuous hemodiafiltration: a comparative study. Intensive Care Med 1993; 19: 329–332
- Mehta R L. Anticoagulation during continuous renal replacement therapy. ASAIO J 1994; 40(4)931–935
- Langenecker S A, Felfernig M, Werba A, et al. Anticoagulation with prostacyclin and heparin during continuous venovenous hemofiltration. Crit Care Med 1994; 22(11)1774–1781
- Favre H, Martin P Y, Stoermann C. Anticoagulation in continuous extracporeal renal replacement therapy. Sem Dialy 1996; 9(2)112–118
- Mallett S V, Cox D JA. Thromboelastography. Brit J Anaes 1992; 69: 307–313
- Kang Y G, Martin D J, Marquez J, et al. Intraoperative changes in blood co agulation and thromboelastographic monitoring in liver transplantation. Anesth Analg 1985; 64: 888–896
- Tuman K J, Spiess B D, McCarthy R J, et al. Comparison of viscoelastic measures of coagulation after cardiopulmonary bypass. Anesth Analg 1989; 69: 69–75
- Spiess B D, Tuman K J, McCarthy R J, et al. Thromboelastography as an indicator of post-cardiopulmonary bypass coagulopathies. J Clin Monitoring 1987; 3(1)25–30
- Nuttall G A, Oliver W C, Ereth M H, et al. Coagulation tests predict bleeding after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1997; 11(7)815–23
- Bellomo R. Choosing a therapeutic modality: hemofiltration vs hemodialysis vs hemodiafiltration. Sem Dial 1996; 9(2)88–92
- Ronco C, Barbacini S, Digito A, Zoccali G. Achievements and new directions in continuous renal replacement therapies. New Horiz 1995; 3(4)708–716
- Ward D M, Mehta R L. Extracorporeal management of acute renal failure patients at high risk of bleeding. Kidney Int 1993; 43(S41)237–244
- Webb A R, Mythen M G, Jacobson D, Mackie I J. Maintaining blood flow in the extracorporeal circuit: haemostasis and anticoagulation. Intensive Care Med 1995; 21: 84–93
- Mehta R L, Dobos G J, Ward D M. Anticoagulation in continuous renal replacement procedures. Sem Dialy 1992; 5(1)61–68
- Leslie G D, Jacobs I G, Clarke G M. Proximally delivered dilute heparin does not improve circuit life in continuous venovenous haemodiafiltration. Intensive Care Med 1996; 22: 1261–1264
- Derrier M, Jambou P, Kaidomar M, et al. Thromboelastography and monitoring of coagulation in patients undergoing continuous venovenous hemofiltration. Contrib Nephrol 1995; 116: 159–62
- Essell J H, Martin T J, Salinas J, et al. Comparison of thromboelastography to bleeding time and standard coagulation tests in patients after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1993; 7(4)410–415
- Dorman B H, Spinale F G, Bailey M K, et al. Identification of patients at risk for excessive blood loss during coronary artery bypass: thromboelastography versus coagulation screen. Anesth Analg 1993; 76(4)694–700
- Lane D A, Bowry S K. The scientific basis for selection of measures of thrombogenicity. Nephrol Dial Transplant 1993; 9(S2)18–28
- Davenport A. The coagulation system in the critically ill patient with acute renal failure and the effect of an extracorporeal circuit. Am J Kidney Dis 1997; 30(5S4)S20–S27
- Bastien O, French P, Paulus S, et al. Antithrombin III deficiency during continuous venovenous hemodialysis. Contrib Nephrol 1995; 116: 154–158
- Yohay D A, Butterly D W, Schwab S J, et al. Continuous arteriovenous hemodialysis: Effect of dialyzer geometry. Kidney Int 1992; 42: 448–451
- Baldwin I C, Elderkin T D. Continuous hemofiltration: Nursing perspective in Critical Care. New Horiz 1995; 3(4)738–747